Axm Pharma, Inc. Receives Notification Letter From Axm Pharma, Inc. ; Company's Common Stock To Continue To Be Listed

Published: Dec 27, 2005

LAS VEGAS--(BUSINESS WIRE)--Dec. 23, 2005--AXM Pharma, Inc. (AMEX: AXJ), a manufacturer of proprietary and generic pharmaceutical and nutraceutical products for the Chinese and other Asian markets, announced today that it has received notification from the American Stock Exchange ("Amex") that its common stock will continue to trade on the Exchange as a result of the Company filing its Form 10-Q for the period ended September 30, 2005. The Company's common stock will continue to remain on the AMEX as long as it meets the requirements for continued listing.

Back to news